VANTAGE CONSULTING GROUP INC – Bristol-Myers Squibb Company Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$260,000
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.15% | 454 shares | 13K | $71.09 | 3.66K |
| Q2 2022 | share | Decrease | -3.81% | -127 shares | 3K | $77 | 3.20K |
| Q1 2022 | share | Decrease | -27.75% | -1.28K shares | -44K | $73.03 | 3.33K |
| Q4 2021 | share | Increase | +19.83% | 764 shares | 60K | $62.52 | 4.61K |
| Q3 2021 | share | Increase | +14.44% | 486 shares | 3K | $59.17 | 3.85K |
| Q2 2021 | share | Increase | 0.00% | 3.36K shares | 225K | $65.79 | 3.36K |
| Q1 2021 | share | Decrease | -100.00% | -1.20K shares | -74K | $62.15 | 0 |
| Q4 2020 | share | Increase | 0.00% | 1.20K shares | 74K | $60.6 | 1.20K |